Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the rapid expansion is under scrutiny amid cost pressures, and the new CEO is ...

Obesity and diabetes rates in Mississippi are near the highest in the U.S.. In an effort to address the state's obesity epidemic and subsequently address the health effects associated with it, the ...

Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

Fact checked by Vikki Velasquez Key Takeaways Most underwriting forms don’t ask about GLP-1 drug use, creating blind spots for insurers as they price policies.Most patients stop GLP-1 drugs within a ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

The hiring freeze will apply across all markets and departments, with the exception of business-critical roles, a spokeswoman said.

HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...

While health insurance premiums have been increasing, 2026 will see the largest hike in prices since 2018, according to KFF ...

Karren Brady is a hero of mine. Exactly my age at 56, she's an icon I've always worshipped: a woman of hard head and good ...